Global metabolomic profiling reveals hepatic biosignatures that reflect the unique metabolic needs of late‐term mother and fetus
- 7 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Metabolomics
- Vol. 17 (2), 1-13
- https://doi.org/10.1007/s11306-021-01773-8
Abstract
Objective Gestational disorders including preeclampsia, growth restriction and diabetes are characterized, in part, by altered metabolic interactions between mother and fetus. Understanding their functional relevance requires metabolic characterization under normotypic conditions. Methods We performed untargeted metabolomics on livers of pregnant, late-term C57Bl/6J mice (N = 9 dams) and their fetuses (pooling 4 fetuses/litter), using UPLC-MS/MS. Results Multivariate analysis of 730 hepatic metabolites revealed that maternal and fetal metabolite profiles were highly compartmentalized, and were significantly more similar within fetuses (ρaverage = 0.81), or within dams (ρaverage = 0.79), than within each maternal-fetal dyad (ρaverage = − 0.76), suggesting that fetal hepatic metabolism is under distinct and equally tight metabolic control compared with its respective dam. The metabolite profiles were consistent with known differences in maternal-fetal metabolism. The reduced fetal glucose reflected its limited capacity for gluconeogenesis and dependence upon maternal plasma glucose pools. The fetal decreases in essential amino acids and elevations in their alpha-keto acid carnitine conjugates reflects their importance as secondary fuel sources to meet fetal energy demands. Whereas, contrasting elevations in fetal serine, glycine, aspartate, and glutamate reflects their contributions to endogenous nucleotide synthesis and fetal growth. Finally, the elevated maternal hepatic lipids and glycerol were consistent with a catabolic state that spares glucose to meet competing maternal-fetal energy demands. Conclusions The metabolite profile of the late-term mouse dam and fetus is consistent with prior, non-rodent analyses utilizing plasma and urine. These data position mouse as a suitable model for mechanistic investigation into how maternal-fetal metabolism adapts (or not) to gestational stressors.Funding Information
- National Institutes of Health (R01 AA022999, R01 AA011085, F32 AA027121, T32 DK007686)
This publication has 63 references indexed in Scilit:
- In utero fuel homeostasis: Lessons for a clinicianIndian Journal of Endocrinology and Metabolism, 2013
- Software Techniques for Enabling High-Throughput Analysis of Metabolomic DatasetsPublished by IntechOpen ,2012
- Organization of GC/MS and LC/MS metabolomics data into chemical librariesJournal of Cheminformatics, 2010
- Maternal Nutrition and Birth OutcomesEpidemiologic Reviews, 2010
- Recent observations on the regulation of fetal metabolism by glucoseJournal Of Physiology-London, 2006
- Glutathione in the developing mouse liver—I: Developmental curve and depletion after acetaminophen treatmentBiochemical Pharmacology, 1976
- A Review: Biological and Clinical Aspects of Pyrimidine MetabolismPediatric Research, 1974
- The Biological Significance of Purine SalvageAnnual Review of Biochemistry, 1971
- DEVELOPMENT OF UREA-SYNTHESIZING ENZYMES IN HUMAN LIVERActa Paediatrica, 1968
- Glucose Metabolism in the Fetus in Utero: The Effect of Maternal Fasting and Glucose Loading in the RatPediatric Research, 1967